Latest Stories
5 Must-Read Analyst Questions From Washington Trust Bancorp’s Q4 Earnings Call
Washington Trust Bancorp’s fourth quarter was marked by stronger-than-expected performance, highlighted by expanding profit margins and notable growth in both deposit and wealth management revenues. Management attributed the outperformance to a more favorable funding mix, disciplined deposit rate management, and targeted investments in key business lines. CEO Ned Handy emphasized, “The quarter’s performance was driven by margin expansion, continued in-market deposit growth and increased revenues from wealth management.” Additionally, the company cited improved asset quality metrics and a normalized provision for credit losses as contributing factors.
HLNE Q4 Deep Dive: Product Mix Shift and Evergreen Platform Growth Shape Outlook
Alternative investment management firm Hamilton Lane (NASDAQ:HLNE) reported revenue ahead of Wall Streets expectations in Q4 CY2025, with sales up 18.2% year on year to $198.9 million. Its non-GAAP profit of $1.55 per share was 16.9% above analysts’ consensus estimates.
GWW Q4 Deep Dive: Technology Investments and Market Share Gains Drive Results Amid Macro Headwinds
Maintenance and repair supplier W.W. Grainger (NYSE:GWW) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 4.5% year on year to $4.43 billion. The company expects the full year’s revenue to be around $18.9 billion, close to analysts’ estimates. Its GAAP profit of $9.44 per share was 4.1% below analysts’ consensus estimates.
MDLZ Q4 Deep Dive: Margin Compression Amid Pricing, Cocoa Volatility, and Shifting Consumer Trends
Packaged snacks company Mondelez (NASDAQ:MDLZ) reported revenue ahead of Wall Streets expectations in Q4 CY2025, with sales up 9.3% year on year to $10.5 billion. Its non-GAAP profit of $0.72 per share was 3.3% above analysts’ consensus estimates.
EMR Q4 Deep Dive: Automation, AI, and Power Drive Growth Amid Regional Divergence
Engineering and automation solutions company Emerson (NYSE:EMR) met Wall Streets revenue expectations in Q4 CY2025, with sales up 4.1% year on year to $4.35 billion. Its non-GAAP profit of $1.46 per share was 3.4% above analysts’ consensus estimates.
CMG Q4 Deep Dive: Value Push, Menu Innovation, and Margins Under Pressure
Mexican fast-food chain Chipotle (NYSE:CMG) announced better-than-expected revenue in Q4 CY2025, with sales up 4.9% year on year to $2.98 billion. Its non-GAAP profit of $0.25 per share was 4.9% above analysts’ consensus estimates.
INGR Q4 Deep Dive: Clean Label and Solutions Growth Offset by Operational Challenges
Food ingredient solutions provider Ingredion (NYSE:INGR) fell short of the markets revenue expectations in Q4 CY2025, with sales falling 2.4% year on year to $1.76 billion. Its non-GAAP profit of $2.53 per share was 3.1% below analysts’ consensus estimates.
HRB Q4 Deep Dive: Assisted Tax Prep and AI Investments Shape Future Strategy
Tax preparation company H&R Block (NYSE:HRB) reported revenue ahead of Wall Streets expectations in Q4 CY2025, with sales up 11.1% year on year to $198.9 million. The company expects the full year’s revenue to be around $3.89 billion, close to analysts’ estimates. Its non-GAAP loss of $1.84 per share was 2.8% above analysts’ consensus estimates.
CSL Q4 Deep Dive: Reroofing Demand and Product Innovation Offset Construction Weakness
Building envelope solutions provider Carlisle Companies (NYSE:CSL) beat Wall Street’s revenue expectations in Q4 CY2025, but sales were flat year on year at $1.13 billion. Its non-GAAP profit of $3.90 per share was 8.9% above analysts’ consensus estimates.
AMGN Q4 Deep Dive: Product Portfolio Expansion and Pipeline Progress Drive Outlook
Biotech company Amgen (NASDAQ:AMGN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 8.6% year on year to $9.87 billion. The company’s full-year revenue guidance of $37.7 billion at the midpoint came in 1.7% above analysts’ estimates. Its non-GAAP profit of $5.29 per share was 11.9% above analysts’ consensus estimates.